Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Harmony Biosciences Holdings, Inc. (HRMY) had Free Cash Flow of $219.07M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$582.02M |
|
$128.85M |
|
$121.24M |
|
$460.79M |
|
$389.99M |
|
$192.03M |
|
$-18.63M |
|
$173.40M |
|
$173.40M |
|
$128.85M |
|
$128.85M |
|
$128.85M |
|
$128.85M |
|
$192.03M |
|
$215.95M |
|
59.47M |
|
60.37M |
|
$2.17 |
|
$2.13 |
|
| Balance Sheet Financials | |
$451.07M |
|
$0.37M |
|
$360.38M |
|
$811.45M |
|
$163.78M |
|
$178.57M |
|
$180.68M |
|
$344.46M |
|
$466.99M |
|
$329.88M |
|
$466.99M |
|
56.77M |
|
| Cash Flow Statement Financials | |
$219.39M |
|
$-46.44M |
|
$-105.55M |
|
$244.53M |
|
$311.93M |
|
$67.40M |
|
$31.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.75 |
|
-- |
|
-- |
|
0.28 |
|
0.41 |
|
79.17% |
|
32.99% |
|
32.99% |
|
37.10% |
|
29.79% |
|
22.14% |
|
|
Free Cash Flow |
$219.07M |
-- |
|
-- |
|
-- |
|
0.72 |
|
22.61 |
|
7.85 |
|
46.49 |
|
27.59% |
|
39.06% |
|
15.88% |
|
19.96% |
|
$8.23 |
|
$3.63 |
|
$3.63 |
|